Evidence map›Paper›PMID 29955439›Full record

ArticleNature biomedical engineering2018

Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy.

Sazid Hussain, Jinmyoung Joo, Jinyoung Kang, Byungji Kim, Gary B Braun, Zhi-Gang She, Dokyoung Kim, Aman P Mann, Tarmo Mölder, Tambet Teesalu and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature biomedical engineering, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 142 papers.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed
32.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 384 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Metformin-loaded J-AuPPS for infected diabetic wound treatment.Frontiers in bioengineering and biotechnology · 2026
    Article
  12. Article
  13. Biofilm-associated genes inFrontiers in microbiology · 2026
    Review
  14. Article
  15. Avian PathogenicVeterinary sciences · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Modification of Porous Silicon with an Amphiphilic Quaternary Ammonium Hydrocarbon for Nanomedicine Applications.Chemistry of materials : a publication of the American Chemical Society · 2025
    Article
  20. Article

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 6 countries.

Sazid HussainCancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Jinmyoung JooDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-1574-9842
Jinyoung KangDepartment of Nanoengineering, University of California, San Diego, La Jolla, CA, USA.
Byungji KimMaterials Science and Engineering Program, University of California, San Diego, La Jolla, CA, USA.
Gary B BraunCancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Zhi-Gang SheCancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Dokyoung KimDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-7756-3560
Aman P MannCancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Tarmo MölderLaboratory of Cancer Biology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Tambet TeesaluCancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Santina CarnazzaDipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali- ChiBioFarAm, Università di Messina, Messina, Italy.
Salvatore GuglielminoDipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali- ChiBioFarAm, Università di Messina, Messina, Italy.
Michael J SailorDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-4809-9826
Erkki RuoslahtiCancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. ruoslahti@sbpdiscovery.org.
Sanford Burnham Prebys Medical Discovery Institute · USUniversity of California San Diego · USUniversity of California, Santa Barbara · USUniversity of Messina · ITUlsan College · KRUniversity of Tartu · EE

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Maximiliano A DAngelo · 1985 to 2026
$107.2M
Macrophage-targeting Nanoplatforms as Immunotherapy against Pulmonary InfectionsR01AI132413 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Michael J Sailor · 2017 to 2026
$6.0M
NCI NIH HHS P30 CA030199NIAID NIH HHS R01 AI132413
6 · The paper itself

Abstract

Bacterial resistance to antibiotics has made it necessary to resort to antibiotics that have considerable toxicities. Here, we show that the cyclic 9-amino acid peptide CARGGLKSC (CARG), identified via phage display on

Identifiers

PMID29955439
PMCPMC6015743
OpenAlexW2789337312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.